Cover
Cover | Feb. 03, 2022 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | In its Current Report on Form 8-K dated February 3, 2022 (the “Original Report”), the Company reported the retirement of Stephen H. Rusckowski, the Company’s current Chairman, Chief Executive Officer and President, and the appointment of James E. Davis as its next Chief Executive Officer and President, to be effective November 1, 2022. This Current Report on Form 8-K/A amends the Original Report to provide information about changes to Mr. Rusckowski’s arrangements in connection with his retirement as Chief Executive Officer and President on November 1, 2022 and his service as Executive Chairman of the Company until March 31, 2023. |
Document Period End Date | Feb. 03, 2022 |
Entity File Number | 001-12215 |
Entity Registrant Name | Quest Diagnostics Incorporated |
Entity Central Index Key | 0001022079 |
Entity Tax Identification Number | 16-1387862 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 500 Plaza Drive |
Entity Address, City or Town | Secaucus |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 07094 |
City Area Code | (973) |
Local Phone Number | 520-2700 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.01 Par Value |
Trading Symbol | DGX |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |